2025年度 第2四半期（中間期）決算説明会

This document summarizes the results of Riken Vitamin Co., Ltd.'s second quarter (interim) financial results for the fiscal year 2025. The company reported a revenue of 47.2 billion yen, reflecting a 0.2% increase compared to the same period last year, while operating profit decreased by 11.6% to 4 billion yen. The domestic business showed improvement due to reduced advertising expenses, but the overseas segment faced challenges from poor sales in China and intensified price competition. Despite a 3.3% increase in net profit attributable to the parent company, revenue fell short of initial forecasts. Future strategies will need to focus on revising sales approaches both domestically and internationally.